Population
1 30-year-old man with a 3-year history of tardive dyskinesia
Design
Case_report
Authors
Loading...
May complicate NMS diagnosis amid tardive dyskinesia; leaves open bromocriptine efficacy pending controlled data.
Pre-existing tardive dyskinesia can confuse the presentation and delay the diagnosis of neuroleptic malignant syndrome, which may improve with bromocriptine.
Haggerty et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: